how safe are glp 1 Pharmacological interventions for obesity in patients with inflammatory bowel disease: A systematic review of GLP-1 receptor agonist efficacy and safety GLP-1 Medications for Weight Loss:

2025;48:zsae280

Again, these aren't new, but the conversation around it is so new being in the general public is often women's periods, reproductive health

Tirzepatide is the proven, high-efficacy standard for dual agonism

For example, in the case of amylin biology, significant translational gaps between rodent and human systems persist, the optimal receptor selectivity profile for clinical use remains unclear, and molecules continue to advance in clinical development despite these uncertainties (Hollander et al., 2020)

In the UK, NICE recommends GLP-1 receptor agonists for type 2 diabetes in specific circumstances (NG28), such as when metformin is insufficient and BMI 30 kg/m

Within this model, behavioral weight loss counseling and referrals to RDN and MNT as part of a comprehensive treatment plan are emphasized [12]